Literature DB >> 4092729

Central serotonergic responses and behavioural adaptation to repeated immobilisation: the effect of the corticosterone synthesis inhibitor metyrapone.

G A Kennett, S L Dickinson, G Curzon.   

Abstract

Rats were immobilised for 2 h/day. Twenty-four hours after the 1, 3 or 7 immobilisation periods they were injected with the 5HT agonist 5-methoxy-N,N-dimethyltryptamine (5MeODMT; 5 mg/kg i.p.) and behavioural responses (i.e. hind limb abduction, forepaw treading, head weaving, tremor, Straub tail) compared with those of a control group. As we have previously observed after 7 (but not after 1 or 3 immobilisations) forepaw treading and tremor were enhanced and the other responses unaffected. Pretreatment with metyrapone (a corticosterone synthesis inhibitor 150 mg/kg i.p., 3 h before each immobilisation) did not affect the above responses to 1 immobilisation, increased tremor after 3 immobilisations and also increased forepaw treading, hind limb abduction and Straub tail after 7 immobilisations but decreased head weaving under the latter conditions. Metyrapone without immobilisation had no effect on responses to 5MeODMT. Twenty four hours after 1 or 3 (but not 7) immobilisation periods, rats placed for the first time in an open field showed less locomotion and rearing and more defaecation than control animals. Rats also given metyrapone exhibited normal open field behaviour after only 3 immobilisations. The drug also accelerated the return to normal on repeated immobilisation of the impairment of food intake and growth rate which occurred after a single immobilisation. The results as a whole suggest that metyrapone promotes behavioural adaptation to repeated immobilisation and that this is associated with enhanced postsynaptic responses to 5HT. These findings suggest that immobilisation stress-induced changes might be relevant as an animal model for depression which incorporates reported biochemical abnormalities in the illness and is of relevance to proposals concerning its precipitation by stress.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4092729     DOI: 10.1016/0014-2999(85)90290-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  19 in total

Review 1.  The 5-HT receptor--G-protein--effector system complex in depression. I. Effect of glucocorticoids.

Authors:  K P Lesch; B Lerer
Journal:  J Neural Transm Gen Sect       Date:  1991

2.  Quantitative trait loci associated with the behavioral response of B x D recombinant inbred mice to restraint stress: a preliminary communication.

Authors:  B J Tarricone; J N Hingtgen; J K Belknap; S R Mitchell; J I Nurnberger
Journal:  Behav Genet       Date:  1995-09       Impact factor: 2.805

3.  Desipramine and restraint stress induce odor conditioned aversion in rats: suppression by repeated conditioning.

Authors:  V S Murua; V A Molina
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

4.  Serotonergic neurotransmission in the ventral hippocampus is enhanced by corticosterone and altered by chronic amphetamine treatment.

Authors:  J L Barr; G L Forster
Journal:  Neuroscience       Date:  2011-03-21       Impact factor: 3.590

5.  Repeated restraint stress reduces opioid receptor binding in different rat CNS structures.

Authors:  Giovana Dantas; Iraci Lucena Da Silva Torres; Leonardo Machado Crema; Diogo R Lara; Carla Dalmaz
Journal:  Neurochem Res       Date:  2005-01       Impact factor: 3.996

6.  Tramadol and another atypical opioid meperidine have exaggerated serotonin syndrome behavioural effects, but decreased analgesic effects, in genetically deficient serotonin transporter (SERT) mice.

Authors:  Meredith A Fox; Catherine L Jensen; Dennis L Murphy
Journal:  Int J Neuropsychopharmacol       Date:  2009-03-11       Impact factor: 5.176

7.  Repeated restraint stress alters hippocampal glutamate uptake and release in the rat.

Authors:  Fernanda Urruth Fontella; Deusa Aparecida Vendite; Angela Sampaio Tabajara; Lisiane O Porciúncula; Iraci Lucena da Silva Torres; Flúvia Melina Jardim; Lúcia Martini; Diogo O Souza; Carlos Alexandre Netto; Carla Dalmaz
Journal:  Neurochem Res       Date:  2004-09       Impact factor: 3.996

Review 8.  Innovative approaches for the treatment of depression: targeting the HPA axis.

Authors:  Fiona Thomson; Mark Craighead
Journal:  Neurochem Res       Date:  2007-10-25       Impact factor: 3.996

9.  5-HT1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats.

Authors:  Leonardo B M Resstel; Rodrigo F Tavares; Sabrina F S Lisboa; Sâmia R L Joca; Fernando M A Corrêa; Francisco S Guimarães
Journal:  Br J Pharmacol       Date:  2009-01       Impact factor: 8.739

10.  5-Hydroxytryptamine is biotransformed by CYP2C9, 2C19 and 2B6 to hydroxylamine, which is converted into nitric oxide.

Authors:  Caroline Fradette; Nobuharu Yamaguchi; Patrick Du Souich
Journal:  Br J Pharmacol       Date:  2004-01-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.